Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry a retrospective cohort study

Eduard A van Bodegraven, Tess M E van Ramshorst, Svein O Bratlie, European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS), Arto Kokkola, Ernesto Sparrelid, Bergthor Björnsson, Dyre Kleive, Stefan K Burgdorf, Safi Dokmak, Bas Groot Koerkamp, Santiago Sánchez Cabús, I Quintus Molenaar, Ugo Boggi, Olivier R Busch, Miha Petrič, Geert Roeyen, Thilo Hackert, Daan J Lips, Mathieu D'HondtMariëlle M E Coolsen, Giovanni Ferrari, Bobby Tingstedt, Alejandro Serrablo, Sebastien Gaujoux, Marco Ramera, Igor Khatkov, Fabio Ausania, Regis Souche, Sebastiaan Festen, Frederik Berrevoet, Tobias Keck, Robert P Sutcliffe, Elizabeth Pando, Roeland F de Wilde, Beatrice Aussilhou, Paul S Krohn, Bjørn Edwin, Per Sandström, Stefan Gilg, Hanna Seppänen, Caroline Vilhav, Mohammad Abu Hilal, Marc G Besselink

Research output: Contribution to journalArticleAcademicpeer-review

8 Downloads (Pure)


BACKGROUND: International guidelines recommend monitoring the use and outcome of minimally invasive pancreatic surgery (MIPS). However, data from prospective international audits on minimally invasive distal pancreatectomy (MIDP) are lacking. This study examined the use and outcome of robot-assisted (RDP) and laparoscopic (LDP) distal pancreatectomy in the E-MIPS registry. PATIENTS AND METHODS: Post-hoc analysis in a prospective audit on MIPS, including consecutive patients undergoing MIDP in 83 centers from 19 European countries (01-01-2019/31-12-2021). Primary outcomes included intraoperative events (grade 1: excessive blood loss, grade 2: conversion/change in operation, grade 3: intraoperative death), major morbidity, and in-hospital/30-day mortality. Multivariable logistic regression analyses identified high-risk groups for intraoperative events. RDP and LDP were compared in the total cohort and high-risk groups. RESULTS: Overall, 1672 patients undergoing MIDP were included; 606 (36.2%) RDP and 1066 (63.8%) LDP. The annual use of RDP increased from 30.5% to 42.6% ( P <0.001). RDP was associated with fewer grade 2 intraoperative events compared with LDP (9.6% vs. 16.8%, P <0.001), with longer operating time (238 vs. 201 min, P <0.001). No significant differences were observed between RDP and LDP regarding major morbidity (23.4% vs. 25.9%, P =0.264) and in-hospital/30-day mortality (0.3% vs. 0.8%, P =0.344). Three high-risk groups were identified; BMI greater than 25 kg/m 2 , previous abdominal surgery, and vascular involvement. In each group, RDP was associated with fewer conversions and longer operative times. CONCLUSION: This European registry-based study demonstrated favorable outcomes for MIDP, with mortality rates below 1%. LDP remains the predominant approach, whereas the use of RDP is increasing. RDP was associated with fewer conversions and longer operative time, including in high-risk subgroups. Future randomized trials should confirm these findings and assess cost differences.

Original languageEnglish
Pages (from-to)3554-3561
Number of pages8
JournalInternational journal of surgery (London, England)
Issue number6
Early online date18 Mar 2024
Publication statusPublished - 1 Jun 2024

Bibliographical note

Publisher Copyright:
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.


Dive into the research topics of 'Minimally invasive robot-assisted and laparoscopic distal pancreatectomy in a pan-European registry a retrospective cohort study'. Together they form a unique fingerprint.

Cite this